-
公开(公告)号:US09643953B2
公开(公告)日:2017-05-09
申请号:US14365895
申请日:2012-12-17
发明人: Marion Hitchcock , Anne Mengel , Anja Richter , Hans Briem , Knut Eis , Vera Pütter , Gerhard Siemeister , Stefan Prechtl , Amaury Ernesto Fernández-Montalván , Christian Stegmann , Simon Holton , Mark Jean Gnoth , Cornelia Preuβe
IPC分类号: C07D401/14 , A61K31/506 , C07D405/14
CPC分类号: C07D401/14 , A61K31/506 , C07D405/14
摘要: Compounds of formula (I) and their use as pharmaceutical.
-
公开(公告)号:US09422268B2
公开(公告)日:2016-08-23
申请号:US14365895
申请日:2012-12-17
发明人: Marion Hitchcock , Anne Mengel , Anja Richter , Hans Briem , Knut Eis , Vera Pütter , Gerhard Siemeister , Stefan Prechtl , Amaury Ernesto Fernández-Montalván , Christian Stegmann , Simon Holton , Mark Jean Gnoth , Cornelia Preuβe
IPC分类号: C07D401/14 , A61K31/506 , C07D405/14
摘要: Compounds of formula (I) and their use as pharmaceutical.
-
公开(公告)号:US09265763B2
公开(公告)日:2016-02-23
申请号:US14350160
申请日:2012-10-04
发明人: Marion Hitchcock , Anne Mengel , Vera Pütter , Gerhard Siemeister , Antje Margret Wengner , Hans Briem , Knut Eis , Volker Schulze , Amaury Ernesto Fernandez-Montalvan , Stefan Prechtl , Simon Holton , Jörg Fanghänel , Philip Lienau , Cornelia Preusse , Mark Jean Gnoth
IPC分类号: C07D401/14 , A61K31/506 , C07D405/14 , C07D413/14 , C07D498/04 , A61K31/5377 , A61K31/5383 , A61K45/06
摘要: Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
-
公开(公告)号:US20140315934A1
公开(公告)日:2014-10-23
申请号:US14365895
申请日:2012-12-17
发明人: Marion Hitchcock , Anne Mengel , Anja Richter , Hans Briem , Knut Eis , Vera Pütter , Gerhard Siemeister , Stefan Prechtl , Amaury Ernesto Fernandez-Montalvan , Christian Stegmann , Simon Holton , Mark Jean Gnoth , Cornelia Preuße
IPC分类号: C07D401/14 , C07D405/14 , A61K31/506
CPC分类号: C07D401/14 , A61K31/506 , C07D405/14
摘要: Compounds of formula (I) and their use as pharmaceutical.
摘要翻译: 式(I)化合物及其作为药物的用途。
-
公开(公告)号:US10604532B2
公开(公告)日:2020-03-31
申请号:US16360811
申请日:2019-03-21
发明人: Marion Hitchcock , Anne Mengel , Vera Pütter , Gerhard Siemeister , Antje Margret Wengner , Hans Briem , Knut Eis , Volker Schulze , Amaury Ernesto Fernandez-Montalvan , Stefan Prechtl , Simon Holton , Jörg Fanghänel , Philip Lienau , Cornelia Preusse , Mark Jean Gnoth
IPC分类号: C07D401/14 , C07D498/04 , C07D405/14 , C07D413/14 , A01H6/36 , A61K31/506 , A61K31/5377 , A61K31/5383 , A61K45/06 , C07D403/04
摘要: Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.
-
公开(公告)号:US09260412B2
公开(公告)日:2016-02-16
申请号:US14365895
申请日:2012-12-17
发明人: Marion Hitchcock , Anne Mengel , Anja Richter , Hans Briem , Knut Eis , Vera Pütter , Gerhard Siemeister , Stefan Prechtl , Amaury Ernesto Fernández-Montalván , Christian Stegmann , Simon Holton , Mark Jean Gnoth , Cornelia Preuβe
IPC分类号: C07D401/14 , A61K31/506 , C07D405/14
摘要: Compounds of formula (I) and their use as pharmaceutical.
-
公开(公告)号:US10266548B2
公开(公告)日:2019-04-23
申请号:US15438254
申请日:2017-02-21
发明人: Marion Hitchcock , Anne Mengel , Vera Pütter , Gerhard Siemeister , Antje Margret Wengner , Hans Briem , Knut Eis , Volker Schulze , Amaury Ernesto Fernandez-Montalvan , Stefan Prechtl , Simon Holton , Jörg Fanghänel , Philip Lienau , Cornelia Preusse , Mark Jean Gnoth
IPC分类号: C07D401/14 , C07D498/04 , C07D405/14 , C07D413/14 , A61K31/506 , A61K31/5377 , A61K31/5383 , A61K45/06 , C07D403/04
摘要: Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.
-
公开(公告)号:US20140228370A1
公开(公告)日:2014-08-14
申请号:US14346859
申请日:2012-09-20
发明人: Knut Eis , Florian Puehler , Ludwig Zorn , Arne Scholz , Philip Lienau , Mark Jean Gnoth , Ulf Bömer , Judith Günther
IPC分类号: A61K31/5025 , C07D491/048 , A61K45/06 , C07D487/04
CPC分类号: A61K31/5025 , A61K45/06 , C07D487/04 , C07D491/048
摘要: The present invention relates to substituted imidazopyridazine compounds of general formula (I): in which A, Q, R1, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
摘要翻译: 本发明涉及通式(I)的取代的咪唑并哒嗪化合物:其中A,Q,R 1,R 3,R 4和n如权利要求中所定义,涉及制备所述化合物的方法,可用于制备所述化合物的中间体化合物 涉及包含所述化合物的药物组合物和组合,以及所述化合物用于制备用于治疗或预防疾病,特别是高增殖性和/或血管生成障碍的药物组合物作为唯一试剂或组合的用途 与其他活性成分。
-
公开(公告)号:US09777004B2
公开(公告)日:2017-10-03
申请号:US14388940
申请日:2013-03-27
发明人: Knut Eis , Florian Puehler , Ludwig Zorn , Volker Schulze , Detlev Sülzle , Philip Lienau , Andrea Hägebarth , Kirstin Petersen , Ulf Bömer
IPC分类号: C07D487/04 , A61K31/5025 , A61K31/5377
CPC分类号: C07D487/04 , A61K31/5025 , A61K31/5377
摘要: The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I), in which A, R1, R2, R3, R4, R5 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
-
公开(公告)号:US09643974B2
公开(公告)日:2017-05-09
申请号:US14364181
申请日:2012-12-10
发明人: Knut Eis , Florian Puehler , Ludwig Zorn , Volker Schulze , Detlev Sülzle , Philip Lienau , Andrea Hägebarth , Kirstin Petersen , Ulf Bömer
IPC分类号: C07D491/048 , A61K45/06 , A61K31/5025
CPC分类号: C07D491/048 , A61K31/5025 , A61K45/06 , A61K2300/00
摘要: The present invention relates to amino-substituted imidazopyndazine compounds of general formula (I): in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
-
-
-
-
-
-
-
-
-